American Academy of Ophthalmology (AAO)

New Study Finds Possible Link Between Sight-Threatening Eye Infection and Coronavirus

A cluster of COVID-19 positive patients developed endophthalmitis

Newswise — Researchers are warning of a possible link between a rare and devastating eye infection and COVID-19. In just two months, three patients at New York’s Northwell Health hospital were diagnosed with keratitis that quickly led to endophthalmitis and profound vision loss. One patient’s eye had to be removed. All three patients tested positive for COVID-19. Results of the retrospective review were released this month at AAO 2020 Virtual, the 124th annual meeting of the American Academy of Ophthalmology. The researchers hope their findings will encourage the medical community to consider the eye when evaluating the role of anti-infectious treatment and immunomodulation.

While the evidence does not show that the virus caused the devastating eye infections, the occurrence of keratitis leading to rapid perforation and endophthalmitis is exceedingly rare. To have three cases present over the course of two months in New York, a coronavirus epicenter, is a cause for more investigation, researchers say.

Keratitis is an infected sore on the eye. In rare instances, keratitis can lead to endophthalmitis, an inflammation of fluids inside the eye, usually due to infection caused by various bacteria and fungi. Typically, it’s associated with surgery or trauma. Endophthalmitis can cause significant vision loss, including blindness. In some cases, the eye must be removed. Symptoms typically appear rapidly and include pain, red eye, discharge from the eye, lid swelling and reduced vision.

Ophthalmologist Amilia Schrier, MD, reports that the three patients, all in their 60s, and hailing from Manhattan, Brooklyn, and Long Island, presented to the Northwell Health Ophthalmology Department within the same two-month period. Two were outpatients and one was in the hospital at the time of keratitis diagnosis. All three tested positive for the coronavirus. One of the outpatients was later admitted to the hospital and died. Each patient had a different organism on culture: Streptococcus pneumoniaeSerratia marcescens, and Candida parapsilosis

“The incidence of keratitis progressing to endophthalmitis is extremely low,” Dr. Schrier said. “A 2012 study reported only 27 out of 9,934 eyes in a 15-year period experienced endophthalmitis caused by keratitis.1

Dr. Schrier continued, “three of these cases in a two-month period with COVID-19 positivity suggests that there may be an association between COVID-19 infection and severe eye disease.”

“While these findings do require further research, caution must be undertaken when interpreting these results,” said Sonal S. Tuli, MD, a clinical spokesperson for the Academy who was not involved in the study. “The findings do not suggest that COVID-19 causes endophthalmitis but that there is some relationship between the two. It is possible that some aspect of the health of these individuals made them more liable to get infected with COVID-19 as well as a severe infection in their eye such as a poor immune system or nutritional deficiencies. It is also possible that these findings are incidental because of the large numbers of COVID positive patients presenting to New York hospitals during the peak of the pandemic in New York.”

 

About the American Academy of Ophthalmology

The American Academy of Ophthalmology is the world’s largest association of eye physicians and surgeons. A global community of 32,000 medical doctors, we protect sight and empower lives by setting the standards for ophthalmic education and advocating for our patients and the public. We innovate to advance our profession and to ensure the delivery of the highest-quality eye care. Our EyeSmart® program provides the public with the most trusted information about eye health. For more information, visit aao.org.

 

1 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3490005/




Filters close

Showing results

110 of 4573
Released: 15-Jan-2021 5:40 PM EST
Research Links Social Isolation to COVID-19 Protocol Resistance
Humboldt State University

As health officials continue to implore the public to wear masks and practice social distancing, recent research by Humboldt State University Psychology Professor Amber Gaffney provides key insights into connections between social isolation, conspiratorial thinking, and resistance to COVID-19 protocols.

Newswise: Rapid blood test identifies COVID-19 patients at high risk of severe disease
Released: 15-Jan-2021 5:35 PM EST
Rapid blood test identifies COVID-19 patients at high risk of severe disease
Washington University in St. Louis

Scientists at Washington University School of Medicine in St. Louis have shown that a relatively simple and rapid blood test can predict which patients with COVID-19 are at highest risk of severe complications or death. The blood test measures levels of mitochondrial DNA, which normally resides inside the energy factories of cells. Mitochondrial DNA spilling out of cells and into the bloodstream is a sign that a particular type of violent cell death is taking place in the body.

Released: 15-Jan-2021 2:55 PM EST
COVID-19 deaths really are different. But best practices for ICU care should still apply, studies suggest.
Michigan Medicine - University of Michigan

COVID-19 deaths are indeed different from other lung failure deaths, according to two recent studies, with 56% of COVID-19 patients dying primarily from the lung damage caused by the virus, compared with 22% of those whose lungs fail due to other causes. But, the researchers conclude, the kind of care needed to help sustain people through the worst cases of all forms of lung failure is highly similar, and just needs to be fine-tuned.

Released: 15-Jan-2021 2:50 PM EST
45% of adults over 65 lack online medical accounts that could help them sign up for COVID-19 vaccinations
Michigan Medicine - University of Michigan

As the vaccination of older adults against COVID-19 begins across the country, new poll data suggests that many of them don’t yet have access to the “patient portal” online systems that could make it much easier for them to schedule a vaccination appointment. In all, 45% of adults aged 65 to 80 had not set up an account with their health provider’s portal system.

Released: 15-Jan-2021 1:30 PM EST
New England Journal of Medicine publishes COVID-19 treatment trial results
University of Texas at San Antonio

A clinical trial involving COVID-19 patients hospitalized at UT Health San Antonio and University Health, among roughly 100 sites globally, found that a combination of the drugs baricitinib and remdesivir reduced time to recovery, according to results published Dec. 11 in the New England Journal of Medicine.

Released: 15-Jan-2021 12:40 PM EST
DNA test can quickly identify pneumonia in patients with severe COVID-19, aiding faster treatment
University of Cambridge

Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients.

Released: 15-Jan-2021 12:30 PM EST
Fight CRC To Present Research Findings on The Impact of COVID-19 on the Colorectal Cancer Community at 2021 GI ASCO
Fight Colorectal Cancer

Fight Colorectal Cancer presents abstract at Gastrointestinal Cancer Symposium highlighting the need to address the barriers and opportunities for care within the colorectal cancer community during the COVID-19 pandemic

Released: 15-Jan-2021 12:25 PM EST
Technion to Award Honorary Doctorate to Pfizer CEO Dr. Albert Bourla
American Technion Society

Israel's Technion will award an honorary doctorate to Pfizer CEO and Chairman Dr. Albert Bourla, for leading the development of the novel vaccine against SARS-CoV-2, the virus that causes COVID-19. The honorary doctorate will be conferred at the Technion Board of Governors meeting in November 2021.

Released: 15-Jan-2021 11:30 AM EST
UW researchers develop tool to equitably distribute limited vaccines
University of Wisconsin-Madison

Researchers at the University of Wisconsin School of Medicine and Public Health and UW Health have developed a tool that incorporates a person’s age and socioeconomic status to prioritize vaccine distribution among people who otherwise share similar risks due to their jobs.


Showing results

110 of 4573

close
1.14107